ArticleRheumatology and therapy2024

Characteristics and 6-Month Outcomes in Patients with Rheumatoid Arthritis Initiating Infliximab Biosimilar IFX-dyyb in a Real-World Setting.

Joshua F Baker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.